Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Ischemic Heart Disease

  Free Subscription


Articles published in Prog Cardiovasc Dis

Retrieve available abstracts of 89 articles:
HTML format



Single Articles


    October 2024
  1. LOPES KS, Junior AG, Fillmore N, da Silva Gomes R, et al
    Cardiovascular-kidney-metabolic syndrome - An integrative review.
    Prog Cardiovasc Dis. 2024 Oct 30:S0033-0620(24)00148.
    PubMed     Abstract available


  2. BELMONTE M, Foa A, Paolisso P, Bergamaschi L, et al
    Coronary microvascular dysfunction beyond the spectrum of chronic coronary syndromes.
    Prog Cardiovasc Dis. 2024 Oct 22:S0033-0620(24)00142.
    PubMed     Abstract available


  3. AL ZEIN M, Khazzeka A, El Khoury A, Al Zein J, et al
    Revisiting high-density lipoprotein cholesterol in cardiovascular disease: Is too much of a good thing always a good thing?
    Prog Cardiovasc Dis. 2024 Oct 21:S0033-0620(24)00146.
    PubMed     Abstract available


  4. AL JEBAJE Z, Jabri A, Mishra T, Halboni A, et al
    Use of mechanical circulatory support in high-risk percutaneous coronary interventions.
    Prog Cardiovasc Dis. 2024 Oct 21:S0033-0620(24)00143.
    PubMed     Abstract available


  5. WANG XJ, Voortman T, de Crom TOE, Tilly M, et al
    Healthy and unhealthy plant-based diets and the risk of cardiovascular diseases: The Rotterdam study and updated meta-analysis.
    Prog Cardiovasc Dis. 2024 Oct 21:S0033-0620(24)00144.
    PubMed     Abstract available


  6. RUNSEWE OI, Srivastava SK, Sharma S, Chaudhury P, et al
    Optical coherence tomography angiography in cardiovascular disease.
    Prog Cardiovasc Dis. 2024 Oct 21:S0033-0620(24)00145.
    PubMed     Abstract available


  7. POLO-LOPEZ A, Calatayud J, Lopez-Bueno L, Nunez-Cortes R, et al
    Dose-response association of an accelerometer-measured physical activity with all-cause mortality and cardiovascular disease incidence: Prospective cohort with 76,074 participants.
    Prog Cardiovasc Dis. 2024 Oct 8:S0033-0620(24)00128.
    PubMed     Abstract available


  8. UJJAWAL A, Lobo T, Yaggi HK, Neeland IJ, et al
    The connection between sleep deficiency and coronary artery disease: Complexities and controversies.
    Prog Cardiovasc Dis. 2024 Oct 7:S0033-0620(24)00126.
    PubMed     Abstract available


    September 2024
  9. GAJAGOWNI S, Hopkins S, Qadeer Y, Virani SS, et al
    Clonal hematopoiesis of indeterminate potential and cardiovascular disease: Pathogenesis, clinical presentation, and future directions.
    Prog Cardiovasc Dis. 2024 Sep 13:S0033-0620(24)00117.
    PubMed     Abstract available


  10. POWER DA, Hemetsberger R, Farhan S, Abdel-Wahab M, et al
    Calcified coronary lesions: Imaging, prognosis, preparation and treatment state of the art review.
    Prog Cardiovasc Dis. 2024;86:26-37.
    PubMed     Abstract available


    August 2024
  11. COLLET C, Amponsah DK, Mahendiran T, Mizukami T, et al
    Advancements and future perspectives in coronary angiography-derived fractional flow reserve.
    Prog Cardiovasc Dis. 2024 Aug 7:S0033-0620(24)00111.
    PubMed     Abstract available


  12. LAVIE CJ
    Cardiovascular statistics 2024.
    Prog Cardiovasc Dis. 2024 Aug 5:S0033-0620(24)00103.
    PubMed    


    July 2024
  13. MASOOMI R, Moscardelli S, Hirai T, Azzalini L, et al
    Antegrade techniques for chronic total occlusion percutaneous coronary intervention.
    Prog Cardiovasc Dis. 2024 Jul 18:S0033-0620(24)00098.
    PubMed     Abstract available


  14. KRISHNAN S, Aldana-Bitar J, Golub I, Kianoush S, et al
    Testosterone replacement therapy and cardiovascular risk: TRAVERSE with caution.
    Prog Cardiovasc Dis. 2024 Jul 17:S0033-0620(24)00100.
    PubMed    


    June 2024
  15. MONTONE RA, Ford T, Galli M, Rinaldi R, et al
    Stratified medicine for acute and chronic coronary syndromes: A patient-tailored approach.
    Prog Cardiovasc Dis. 2024 Jun 25:S0033-0620(24)00091.
    PubMed     Abstract available


  16. ROZANSKI A, Gransar H, Park R, Miller RJH, et al
    The ethnic and racial diversity of patients undergoing coronary artery calcium scanning.
    Prog Cardiovasc Dis. 2024 Jun 24:S0033-0620(24)00093.
    PubMed     Abstract available


  17. LOPEZ-BUENO R, Calatayud J, Del Pozo Cruz J, Yang L, et al
    Dose-response associations of the American Heart Association's new "Life's essential 8" metrics with all-cause and cardiovascular mortality in a nationally representative sample from the United States.
    Prog Cardiovasc Dis. 2024 Jun 24:S0033-0620(24)00090.
    PubMed     Abstract available


  18. AROMIWURA AA, Cavalcante JL, Kwong RY, Ghazipour A, et al
    The role of artificial intelligence in cardiovascular magnetic resonance imaging.
    Prog Cardiovasc Dis. 2024 Jun 24:S0033-0620(24)00092.
    PubMed     Abstract available


    May 2024
  19. SOROOSH GP, Tasdighi E, Adhikari R, Blaha MJ, et al
    Coronary artery calcium in 2023: Guidelines for LDL-C goals, non-statin therapies, and aspirin use.
    Prog Cardiovasc Dis. 2024 May 14:S0033-0620(24)00072.
    PubMed     Abstract available


  20. MANUBOLU VS, Ichikawa K, Budoff MJ
    Innovations in cardiac computed tomography: Imaging in coronary artery disease.
    Prog Cardiovasc Dis. 2024 May 14:S0033-0620(24)00073.
    PubMed     Abstract available


  21. GOMEZ S, Dudum R, Rodriguez F
    Inequities in atherosclerotic cardiovascular disease prevention.
    Prog Cardiovasc Dis. 2024 May 9:S0033-0620(24)00071.
    PubMed     Abstract available


  22. GAMI A, Bisht S, Satish P, Blaha MJ, et al
    The utility of coronary artery calcium scoring to enhance cardiovascular risk assessment for South Asian adults.
    Prog Cardiovasc Dis. 2024 May 7:S0033-0620(24)00069.
    PubMed     Abstract available


  23. SATISH P, Avenatti E, Patel J, Agarwala A, et al
    Understanding the spectrum of cardiovascular risk in women - A primer for prevention.
    Prog Cardiovasc Dis. 2024 May 4:S0033-0620(24)00070.
    PubMed     Abstract available


  24. ALDANA-BITAR J, Golub IS, Moore J, Krishnan S, et al
    Colchicine and plaque: A focus on atherosclerosis imaging.
    Prog Cardiovasc Dis. 2024;84:68-75.
    PubMed     Abstract available


    April 2024
  25. JAISWAL V, Sawhney A, Nebuwa C, Borra V, et al
    Association between testosterone replacement therapy and cardiovascular outcomes: A meta-analysis of 30 randomized controlled trials.
    Prog Cardiovasc Dis. 2024 Apr 5:S0033-0620(24)00055.
    PubMed     Abstract available


    March 2024
  26. TUTOR A, O'Keefe EL, Lavie CJ, Elagizi A, et al
    Omega-3 fatty acids in primary and secondary prevention of cardiovascular diseases.
    Prog Cardiovasc Dis. 2024 Mar 26:S0033-0620(24)00054.
    PubMed     Abstract available


  27. LAKSHMANAN S, Wei J, Cook-Wiens G, Pepine CJ, et al
    Comparison of risk profiles of participants in the Women's IschemiA TRial to reduce events in non-ObstRuctive CAD (WARRIOR) trial, using coronary computed tomography angiography vs invasive coronary angiography.
    Prog Cardiovasc Dis. 2024 Mar 26:S0033-0620(24)00053.
    PubMed     Abstract available


  28. LIPPI G, Sanchis-Gomar F, Lavie CJ
    Excess mortality for acute myocardial infarction in the United States during the first two years of the COVID-19 pandemic.
    Prog Cardiovasc Dis. 2024 Mar 20:S0033-0620(24)00051.
    PubMed    


    February 2024
  29. KRISHNAN S, Aldana-Bitar J, Golub I, Ichikawa K, et al
    Testosterone therapy and the risk of cardiovascular disease in older, hypogonadal men.
    Prog Cardiovasc Dis. 2024 Feb 27:S0033-0620(24)00036.
    PubMed     Abstract available


    January 2024
  30. LAVIE CJ
    Over a decade as editor-in-chief at progress in cardiovascular diseases.
    Prog Cardiovasc Dis. 2024 Jan 24:S0033-0620(24)00019.
    PubMed    


  31. GERSH F, O'Keefe JH, Elagizi A, Lavie CJ, et al
    Estrogen and cardiovascular disease.
    Prog Cardiovasc Dis. 2024 Jan 23:S0033-0620(24)00015.
    PubMed     Abstract available


  32. ABDUL-RAHMAN T, Lizano-Jubert I, Bliss ZSB, Garg N, et al
    RNA in cardiovascular disease: A new frontier of personalized medicine.
    Prog Cardiovasc Dis. 2024 Jan 20:S0033-0620(24)00016.
    PubMed     Abstract available


  33. AKHTAR KH, Khan MS, Baron SJ, Zieroth S, et al
    The spectrum of post-myocardial infarction care: From acute ischemia to heart failure.
    Prog Cardiovasc Dis. 2024 Jan 17:S0033-0620(24)00017.
    PubMed     Abstract available


  34. LIPPI G, Mattiuzzi C, Sanchis-Gomar F
    The weekly mortality for ischemic heart disease in the US still peaks on mondays.
    Prog Cardiovasc Dis. 2024 Jan 12:S0033-0620(24)00007.
    PubMed    


    October 2023
  35. ROZANSKI A, Han D, Miller RJH, Gransar H, et al
    Comparison of coronary artery calcium scores among patients referred for cardiac imaging tests.
    Prog Cardiovasc Dis. 2023 Oct 17:S0033-0620(23)00108.
    PubMed     Abstract available


  36. CILIBERTI G, Guerra F, Pizzi C, Merlo M, et al
    Characteristics of patients with recurrent acute myocardial infarction after MINOCA.
    Prog Cardiovasc Dis. 2023 Oct 16:S0033-0620(23)00109.
    PubMed     Abstract available


    July 2023
  37. KRITTANAWONG C, Isath A, Kaplin S, Virk HUH, et al
    Cardiovascular disease in space: A systematic review.
    Prog Cardiovasc Dis. 2023 Jul 31:S0033-0620(23)00075.
    PubMed     Abstract available


  38. LAVIE CJ
    Cardiovascular statistics 2023.
    Prog Cardiovasc Dis. 2023 Jul 18:S0033-0620(23)00071.
    PubMed    


  39. RAWAL H, Nakhle A, Peters M, Srivastav A, et al
    Incidence of acute myocardial infarction and hurricane Katrina: Fourteen years after the storm.
    Prog Cardiovasc Dis. 2023 Jul 5:S0033-0620(23)00067.
    PubMed     Abstract available


    June 2023
  40. ABDUL-RAHMAN T, Lizano-Jubert I, Garg N, Talukder S, et al
    The common pathobiology between coronary artery disease and calcific aortic stenosis: Evidence and clinical implications.
    Prog Cardiovasc Dis. 2023 Jun 9:S0033-0620(23)00058.
    PubMed     Abstract available


    May 2023
  41. NEELAND IJ
    Adipo-cardiology: The next frontier in cardiovascular disease.
    Prog Cardiovasc Dis. 2023 May 6:S0033-0620(23)00049.
    PubMed    


    April 2023
  42. ISATH A, Koziol KJ, Martinez MW, Garber CE, et al
    Exercise and cardiovascular health: A state-of-the-art review.
    Prog Cardiovasc Dis. 2023 Apr 27:S0033-0620(23)00038.
    PubMed     Abstract available


  43. IACOBELLIS G
    Epicardial fat links obesity to cardiovascular diseases.
    Prog Cardiovasc Dis. 2023 Apr 25:S0033-0620(23)00036.
    PubMed     Abstract available


    March 2023
  44. KHAWAJA T, Linge J, Leinhard OD, Al-Kindi SG, et al
    Coronary artery calcium, hepatic steatosis, and atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus: Results from the Dallas heart study.
    Prog Cardiovasc Dis. 2023 Mar 15:S0033-0620(23)00027.
    PubMed     Abstract available


  45. DI FUSCO SA, Aquilani S, Spinelli A, Alonzo A, et al
    The polypill strategy in cardiovascular disease prevention: It's time for its implementation.
    Prog Cardiovasc Dis. 2023 Mar 15:S0033-0620(23)00028.
    PubMed     Abstract available


  46. BANACH M, Penson PE, Farnier M, Fras Z, et al
    Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the international lipid expert panel (ILEP).
    Prog Cardiovasc Dis. 2023 Mar 6:S0033-0620(23)00026.
    PubMed     Abstract available


  47. ROZANSKI A, Sakul S, Narula J, Uretsky S, et al
    Assessment of lifestyle-related risk factors enhances the effectiveness of cardiac stress testing.
    Prog Cardiovasc Dis. 2023;77:95-106.
    PubMed     Abstract available


    February 2023
  48. FIGUEIRO MG, Pedler D
    Cardiovascular disease and lifestyle choices: Spotlight on circadian rhythms and sleep.
    Prog Cardiovasc Dis. 2023 Feb 23:S0033-0620(23)00010.
    PubMed     Abstract available


    January 2023
  49. FAGHY MA, Yates J, Hills AP, Jayasinghe S, et al
    Cardiovascular disease prevention and management in the COVID-19 era and beyond: An international perspective.
    Prog Cardiovasc Dis. 2023 Jan 21:S0033-0620(23)00002.
    PubMed     Abstract available


  50. JOSEPHSON RA, Gillombardo CB
    Cardiovascular services in Covid-19 - Impact of the pandemic and lessons learned.
    Prog Cardiovasc Dis. 2023 Jan 20:S0033-0620(23)00005.
    PubMed     Abstract available


  51. ASHTON RE, Philips BE, Faghy M
    The acute and chronic implications of the COVID-19 virus on the cardiovascular system in adults: A systematic review.
    Prog Cardiovasc Dis. 2023 Jan 20:S0033-0620(23)00004.
    PubMed     Abstract available


  52. LAVIE CJ
    A decade as editor-in-chief of progress in cardiovascular diseases.
    Prog Cardiovasc Dis. 2023;76:118-119.
    PubMed    


  53. HAJRA A, Malik A, Bandyopadhyay D, Goel A, et al
    Impact of COVID-19 in patients hospitalized with stress cardiomyopathy: A nationwide analysis.
    Prog Cardiovasc Dis. 2023;76:25-30.
    PubMed     Abstract available


    December 2022
  54. PRONK NP, Mabry PL, Bond S, Arena R, et al
    Systems science approaches to cardiovascular disease prevention and management in the era of COVID-19: A Humpty-Dumpty dilemma?
    Prog Cardiovasc Dis. 2022 Dec 20:S0033-0620(22)00155.
    PubMed     Abstract available


  55. ARENA R, Faghy M, Laddu D
    A perpetual state of bad dreams: The prevention and management of cardiovascular disease in the COVID-19 pandemic era and beyond.
    Prog Cardiovasc Dis. 2022 Dec 15:S0033-0620(22)00156.
    PubMed    


  56. MATSUSHITA K, Kojima S, Hirakawa K, Tabata N, et al
    Differential effects of overweight/obesity depending on the severity of heart failure complicating acute myocardial infarction in Japan.
    Prog Cardiovasc Dis. 2022 Dec 5:S0033-0620(22)00141.
    PubMed     Abstract available


  57. TUTOR AW, Lavie CJ, Kachur S, Milani RV, et al
    Updates on obesity and the obesity paradox in cardiovascular diseases.
    Prog Cardiovasc Dis. 2022 Dec 5:S0033-0620(22)00134.
    PubMed     Abstract available


  58. LADDU DR, Biggs E, Kaar J, Khadanga S, et al
    The impact of the COVID-19 pandemic on cardiovascular health behaviors and risk factors: A new troubling normal that may be here to stay.
    Prog Cardiovasc Dis. 2022 Dec 5:S0033-0620(22)00138.
    PubMed     Abstract available


  59. FAGHY MA, Ashton REM, Parizher G, Smith A, et al
    COVID-19 and elite sport: Cardiovascular implications and return-to-play.
    Prog Cardiovasc Dis. 2022 Dec 1:S0033-0620(22)00135.
    PubMed     Abstract available


    November 2022
  60. KRITTANAWONG C, Maitra NS, Khawaja M, Wang Z, et al
    Association of pessimism with cardiovascular events and all-cause mortality.
    Prog Cardiovasc Dis. 2022 Nov 30:S0033-0620(22)00139.
    PubMed     Abstract available


  61. AL RIFAI M, Ahmed AI, Alahdab F, Al-Mallah MH, et al
    Clinical utility of coronary artery computed tomography angiography- What we know and What's new?
    Prog Cardiovasc Dis. 2022 Nov 3. pii: S0033-0620(22)00112.
    PubMed     Abstract available


    October 2022
  62. ADABIFIROUZJAEI F, Kimura BJ, Khazai B, DeMaria AN, et al
    Handheld ultrasonography in cardiovascular medicine, updates and controversies.
    Prog Cardiovasc Dis. 2022 Oct 29:S0033-0620(22)00111.
    PubMed     Abstract available


  63. VASUDEVA R, Challa A, Al Rifai M, Polana T, et al
    Prevalence of cardiovascular diseases in COVID-19 related mortality in the United States.
    Prog Cardiovasc Dis. 2022 Oct 21. pii: S0033-0620(22)00098.
    PubMed     Abstract available


    September 2022
  64. ROZANSKI A, Han D, Blaha MJ, Gransar H, et al
    Association between hypercholesterolemia and mortality risk among patients referred for cardiac imaging test: Evidence of a "cholesterol paradox?".
    Prog Cardiovasc Dis. 2022;74:60-69.
    PubMed     Abstract available


  65. MITTAN S, Lee S, Mehra MR
    Artificial intelligence in cardiovascular disease: Challenges and benefits in developing nations.
    Prog Cardiovasc Dis. 2022;74:129-130.
    PubMed    



  66. Introduction for assorted cardiovascular topics II.
    Prog Cardiovasc Dis. 2022;74:1.
    PubMed    


    August 2022
  67. LAVIE CJ
    Progress in Cardiovascular Diseases Statistics 2022.
    Prog Cardiovasc Dis. 2022 Aug 9. pii: S0033-0620(22)00087.
    PubMed    


  68. LAVIE CJ
    Assorted Cardiovascular Topics 2022-Issue I Introduction.
    Prog Cardiovasc Dis. 2022 Aug 9. pii: S0033-0620(22)00088.
    PubMed    


  69. JOSEPHSON RA, Lavie CJ
    Psychological distress in cardiovascular diseases and impact of cardiac rehabilitation programs.
    Prog Cardiovasc Dis. 2022 Aug 9. pii: S0033-0620(22)00086.
    PubMed    


  70. AL RIFAI M, Yao J, Guo X, Post WS, et al
    Association of polygenic risk scores with incident atherosclerotic cardiovascular disease events among individuals with coronary artery calcium score of zero: The multi-ethnic study of atherosclerosis.
    Prog Cardiovasc Dis. 2022 Aug 8. pii: S0033-0620(22)00085.
    PubMed     Abstract available


    July 2022
  71. SAYED A, Munir M, Awad K, Koltowski L, et al
    Are statins beneficial in patients with vasospastic angina? A meta-analysis of observational studies.
    Prog Cardiovasc Dis. 2022;73:88-90.
    PubMed    


    June 2022
  72. IJAZ SH, Minhas AMK, Ghoneem A, Khan SU, et al
    Association of dementia with in-hospital outcomes in primary heart failure and acute myocardial infarction hospitalizations.
    Prog Cardiovasc Dis. 2022 Jun 16. pii: S0033-0620(22)00068.
    PubMed     Abstract available


    May 2022
  73. ISATH A, Howard CE, Virani SS, Wang Z, et al
    Strength training and cardiovascular health: A meta-analysis.
    Prog Cardiovasc Dis. 2022 May 5. pii: S0033-0620(22)00044.
    PubMed    


    March 2022
  74. KIANOUSH S, Al Rifai M, Patel J, George J, et al
    Association of participation in Cardiac Rehabilitation with Social Vulnerability Index: The behavioral risk factor surveillance system.
    Prog Cardiovasc Dis. 2022;71:86-91.
    PubMed     Abstract available


    February 2022
  75. POPOVIC D, Bjelobrk M, Tesic M, Seman S, et al
    Defining the importance of stress reduction in managing cardiovascular disease - the role of exercise.
    Prog Cardiovasc Dis. 2022 Feb 4. pii: S0033-0620(22)00015.
    PubMed     Abstract available


  76. LAVIE CJ
    Nine years as editor-in chief of progress in cardiovascular diseases.
    Prog Cardiovasc Dis. 2022 Feb 1. pii: S0033-0620(22)00018.
    PubMed    


    January 2022
  77. RAO S, Jamal T, Khan MS, Michos E, et al
    Association of polypill therapy with cardiovascular outcomes, mortality, and adherence: A systematic review and meta-analysis of randomized controlled trials.
    Prog Cardiovasc Dis. 2022 Jan 31. pii: S0033-0620(22)00005.
    PubMed     Abstract available


  78. LUTZ AH, Forman DE
    Cardiac rehabilitation in older adults: Apropos yet significantly underutilized.
    Prog Cardiovasc Dis. 2022;70:94-101.
    PubMed     Abstract available


  79. FRANKLIN BA, Quindry J
    High level physical activity in cardiac rehabilitation: Implications for exercise training and leisure-time pursuits.
    Prog Cardiovasc Dis. 2022;70:22-32.
    PubMed     Abstract available


  80. HEINDL B, Ramirez L, Joseph L, Clarkson S, et al
    Hybrid cardiac rehabilitation - The state of the science and the way forward.
    Prog Cardiovasc Dis. 2022;70:175-182.
    PubMed     Abstract available


  81. MAMATAZ T, Uddin J, Ibn Alam S, Taylor RS, et al
    Effects of cardiac rehabilitation in low-and middle-income countries: A systematic review and meta-analysis of randomised controlled trials.
    Prog Cardiovasc Dis. 2022;70:119-174.
    PubMed     Abstract available


    December 2021
  82. KAMINSKY LA, German C, Imboden M, Ozemek C, et al
    The importance of healthy lifestyle behaviors in the prevention of cardiovascular disease.
    Prog Cardiovasc Dis. 2021 Dec 16. pii: S0033-0620(21)00133.
    PubMed     Abstract available


  83. FANAROFF AC, Lopes RD
    The role of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Prog Cardiovasc Dis. 2021 Dec 6. pii: S0033-0620(21)00129.
    PubMed     Abstract available


    November 2021
  84. ASSALI M, Buda KG, Megaly M, Hall AB, et al
    Update on chronic total occlusion percutaneous coronary intervention.
    Prog Cardiovasc Dis. 2021 Nov 23. pii: S0033-0620(21)00123.
    PubMed     Abstract available


  85. LAVIE CJ, Bernasconi A
    Impressive results with EPA, but EPA/DHA combinations also reduce cardiovascular outcomes.
    Prog Cardiovasc Dis. 2021 Nov 15. pii: S0033-0620(21)00121.
    PubMed    


  86. OBRADOVIC D, Freund A, Feistritzer HJ, Sulimov D, et al
    Temporary mechanical circulatory support in cardiogenic shock.
    Prog Cardiovasc Dis. 2021;69:35-46.
    PubMed     Abstract available


    October 2021
  87. SMITH JR, Taylor BJ
    Inspiratory muscle weakness in cardiovascular diseases: Implications for cardiac rehabilitation.
    Prog Cardiovasc Dis. 2021 Oct 21. pii: S0033-0620(21)00116.
    PubMed     Abstract available


    September 2021
  88. MONTONE RA, Jang IK, Beltrame JF, Sicari R, et al
    The evolving role of cardiac imaging in patients with myocardial infarction and non-obstructive coronary arteries.
    Prog Cardiovasc Dis. 2021 Sep 30. pii: S0033-0620(21)00096.
    PubMed     Abstract available


  89. LAVIE CC
    From the editor's desk-overweight and obesity and obesity paradox in cardiovascular diseases.
    Prog Cardiovasc Dis. 2021 Sep 23. pii: S0033-0620(21)00106.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.